Reinforcing Therapist Performance (RTP)
This study has been completed.
Sponsor:
Chestnut Health Systems
Collaborator:
Information provided by:
Chestnut Health Systems
ClinicalTrials.gov Identifier:
NCT01016704
First received: November 18, 2009
Last updated: July 26, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The specific aims of the proposed study are to evaluate the effectiveness and cost-effectiveness of providing monetary incentives to therapists as a method to improve implementation of evidence-based treatments.
| Condition | Intervention |
|---|---|
|
Substance Use |
Behavioral: Incentive |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Reinforcing Therapist Performance |
Further study details as provided by Chestnut Health Systems:
Primary Outcome Measures:
- Target A-CRA [ Time Frame: 14 weeks post intake ] [ Designated as safety issue: No ]Based on a review of recordings of actual client sessions is an indicator of whether or not clients received 10 or more of 12 specified treatment procedures within no less than seven treatment sessions.
- A-CRA Competence [ Time Frame: Monthly ] [ Designated as safety issue: No ]Based on review of a randomly selected session recording is an indicator of whether or not participants delivered at least one treatment procedure at or above the level of competence required as part of the certification process.
Secondary Outcome Measures:
- Percent of days abstinent [ Time Frame: 6 months post-intake ] [ Designated as safety issue: No ]Based on client self report is the percentage of days during the past 90 days that clients reported not using any alcohol or other drugs.
- Pay-for-performance Cost-Effectiveness [ Time Frame: First six months of study ] [ Designated as safety issue: No ]The cost per unit of Target A-CRA, A-CRA Competene, and Percentage of Days Abstient in the experimental condition relative to the control condition.
| Enrollment: | 105 |
| Study Start Date: | November 2008 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| No Intervention: Control | |
| Experimental: Incentive |
Behavioral: Incentive
Participants assigned to the experimental condition are reinforced via monetary incentives for demonstrating superior delivery of an evidence treatment to clients
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Must work at one of the participating demonstration sites funded by the Center for Substance Abuse Treatment to deliver the Adolescent Community Reinforcement Approach and/or Assertive Continuing Care.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01016704
Locations
| United States, Illinois | |
| Lighthouse Institute, Chestnut Health Systems | |
| Normal, Illinois, United States, 61761 | |
Sponsors and Collaborators
Chestnut Health Systems
Investigators
| Principal Investigator: | Bryan R Garner, Ph.D. | Chestnut Health Systems |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Bryan R. Garner, Chestnut Health Systems |
| ClinicalTrials.gov Identifier: | NCT01016704 History of Changes |
| Other Study ID Numbers: | RTP-1, 1R01AA017625-01 |
| Study First Received: | November 18, 2009 |
| Last Updated: | July 26, 2011 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on May 16, 2013